ArticleBMC health services research2020
The development of a legal framework for blood donation and blood safety in China over 24 years.
Article in BMC health services research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 19 citations in OpenAlex.
- Leveraging Behavioral Sciences to Augment Voluntary Blood Donation in China: A Randomized Control Trial and Latent Class Analysis.International journal of behavioral medicine · 2026Trial
- Emergency transfusion of uncross-matched O-type red blood cells in patients with severe pelvic fracture: a multi-center propensity score-weighted analysis.World journal of emergency medicine · 2026Article
- Socioeconomic and Cultural Determinants of Blood Donation Practices Among Underserved Populations.Health science reports · 2026Article
- Determinants of blood transfusion-transmitted infections in donated blood.BMC infectious diseases · 2026Article
- National trends in acute viral hepatitis in China from 1990-2023: An analysis of the Global Burden of Disease 2023 update.Chinese medical journal · 2026Article
- Impact of shifting blood donation policy from gift to honour model: staggered difference-in-differences analysis in China.BMJ (Clinical research ed.) · 2026Article
- The impact of COVID-19 on blood supply-demand balance and the association between group donations and economic performance: evidence from Zhejiang, China.Frontiers in public health · 2026Article
- Institutional Decoupling in China's Blood Donation Reform: Bridging the Gap Between Policy Intentions and Implementation Realities.International journal of health policy and management · 2026Article
- Blood donation trends in Zhejiang Province, 2017-2025: an ecological study before, during, and after COVID-19.Frontiers in public health · 2026Article
- Divergent trends of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), syphilis, and gonorrhea in China: a national age-period-cohort analysis, 2006-2020.Frontiers in public health · 2025Article
- Blood group profile of Türkiye with regional and demographic differences: a 23-year retrospective study.Turkish journal of medical sciences · 2025Article
- Trends and multi-model prediction of hepatitis B incidence in Xiamen.Infectious Disease Modelling · 2024Article
- Prevalence and Residual Risk of HIV in Volunteer Blood Donors of Zhejiang Province, China, from 2018 to 2022.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2024Article
- An Integrative Biology Approach to Quantify the Biodistribution of AzidohomoalanineCellular and molecular bioengineering · 2023Article
- Re-Entry Evaluation of Chinese Blood Donors with Unconfirmed Hepatitis B Screening Results.Viruses · 2022Review
- Predicting willingness to donate blood based on machine learning: two blood donor recruitments during COVID-19 outbreaks.Scientific reports · 2022Article
- Transmitted HIV-1 is more virulent in heterosexual individuals than men-who-have-sex-with-men.PLoS pathogens · 2022Article
- Impact of COVID-19 on Blood Donation and Supply: A Multicenter Cross-Sectional Study from Saudi Arabia.BioMed research international · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundThis study analyzes the regulation of and developments in blood donation in China from 1996 to 2019, and demonstrates the government's efforts to improve blood safety.
resultsSince the implementation of the Blood Donation Law in 1998, the number of blood donors in China increased by 275% from 1998 to 2018 (from 4 million to 15 million). The principle of no-fault liability was proposed and has been applied since 2010 to the tort liability related to blood transfusion malpractice. In 2015, mutual blood donation accounted for 4.2% of the national collection. However, in some provinces of China, the percentage of mutual blood donation increased from 9.3 to 35.6% in 2016. The National Health Commission canceled mutual blood donation in March of 2018. Since 2015, nucleic acid amplification testing has become a routine test item for screening blood.
conclusionsThe Chinese government institutionalized the voluntary non-remunerated donation principle, enacted regulations for the management of blood transfusion, and adopted advanced blood testing technology to sustain blood supply and ensure blood safety. Despite increased blood donation, blood shortages persist. The quality and safety of blood collection can be further improved through the cancellation of mutual blood donation and incentive measures for voluntary non-remunerated donation of blood, which needs facilitation by governmental legislation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.